MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells.

Genes & Cancer
Robert SteeleRatna B Ray

Abstract

c-myc promoter binding protein (MBP-1) is a multi-functional protein known to regulate expression of targets involved in the malignant phenotype. We have previously demonstrated that exogenous expression of MBP-1 inhibits prostate tumor growth, although the mechanism of growth inhibition is not well understood. We hypothesized that MBP-1 may modulate microRNA (miRNA) expression for regulation of prostate cancer cell growth. In this study, we demonstrated that exogenous MBP-1 upregulates miR-29b by 5-9 fold in prostate cancer cells as measured by real-time quantitative reverse transcription-PCR. Subsequent studies indicated that exogenous expression of miR-29b inhibited Mcl-1, COL1A1, and COL4A1. Further, a novel target with potential implications for invasion and metastasis, matrix metallopeptidase-2 (MMP-2), was identified and confirmed to be a miR-29b target in prostate cancer cells. Together our results demonstrated that exogenous expression of miR-29b regulates prostate cancer cell growth by modulating anti-apoptotic and pro-metastatic matrix molecules, implicating therapeutic potential of miR-29b for prostate cancer inhibition.

Citations

Jan 15, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Achim Aigner
Nov 19, 2011·Experimental Brain Research·Guodong ShiLianshun Jia
Feb 5, 2013·Nature Cell Biology·Sonia A Melo, Raghu Kalluri
Feb 16, 2012·Prostate Cancer and Prostatic Diseases·A GordanpourA Seth
Mar 29, 2014·Cancers·Mohammed AbbaHeike Allgayer
Sep 30, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Kasomva KhanmiMichael Gabriel Paulraj
Aug 20, 2011·Expert Opinion on Investigational Drugs·Bridget A QuinnPaul B Fisher
Aug 2, 2013·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·J JonesC Yates
Nov 13, 2014·Journal of Cellular Biochemistry·Jiyun LeeKi-Chul Hwang
Jan 30, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Balraj Singh GillSanjeev Kumar
Jul 23, 2013·Trends in Cardiovascular Medicine·Lars MaegdefesselPhilip S Tsao
Apr 5, 2013·CNS Neuroscience & Therapeutics·Rui-Yan LiChuan-Lu Jiang
Jul 28, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jian-Hong FangShi-Mei Zhuang
Apr 26, 2014·International Journal of Experimental Pathology·Anna M Piccinini, Kim S Midwood
Nov 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Hao LiuLiang Zhao
Jul 21, 2012·Trends in Cardiovascular Medicine·Reinier A Boon, Stefanie Dimmeler
Jul 23, 2011·Biomolecular Concepts·Andrei V Chernov, Alex Y Strongin
Apr 2, 2015·Biochimica Et Biophysica Acta·Cristina CorreiaScott H Kaufmann
Sep 17, 2013·Cell Cycle·Jonathan ChouZena Werb
May 7, 2013·Epigenetics : Official Journal of the DNA Methylation Society·Elsa SousaCarmen Jerónimo
Nov 20, 2012·Matrix Biology : Journal of the International Society for Matrix Biology·Zina Jeyapalan RutnamBurton B Yang
Dec 3, 2014·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Leah CushingJining Lü
Feb 25, 2017·Journal of Cellular Physiology·Lincy EdattSameer V B Kumar
Mar 27, 2018·The Journal of Gene Medicine·Olga E BryzgunovaPavel P Laktionov
Jul 6, 2014·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Sona KollinerovaMartin Modriansky
Aug 23, 2018·Journal of Cellular Biochemistry·Somaye NoruziHamed Mirzaei
Nov 26, 2011·Circulation Research·Denis R MerkMichael P Fischbein
Oct 20, 2011·Circulation. Cardiovascular Genetics·Jeffrey A JonesJohn S Ikonomidis
Feb 15, 2018·Cancer Cell International·Renato F IvanovicSabrina T Reis

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.